Research workbench
Crystal structure of a motavizumab epitope-scaffold bound to motavizumab Fab
Analyse Crystal structure of a motavizumab epitope-scaffold bound to motavizumab Fab in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 3QWO
- Type
- protein
- Length
- 966 residues
- Chains
- 6
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Motavizumab light chain; Motavizumab heavy chain; Motavizumab epitope scaffold
- Ligands
- SO4
- Pockets
- 6 · best druggability 0.75
Structure
x-ray diffraction · 3 distinct chains · 16% helix, 47% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| L, B | Motavizumab light chain | protein | 210 | 6% helix, 55% strand | — |
| H, A | Motavizumab heavy chain | protein | 220 | 8% helix, 51% strand | — |
| C, P | Motavizumab epitope scaffold | protein | 53 | 83% helix, 0% strand | — |
Ligands and binding sites
- SO4 · Sulfate ion · ion · 3 copies · chains L, H, B
- EDO · 1,2-ethanediol · additive · 3 copies · chains H, B, A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 1001 | 0.75 | 0.78 | 124 | empty |
| 2 | 1050 | 0.75 | 0.78 | 109 | EDO |
| 3 | 56 | 0.51 | 0.88 | 20 | empty |
| 4 | 62 | 0.35 | 0.78 | 17 | empty |
| 5 | 64 | 0.28 | 0.73 | 17 | empty |
Interfaces
11 interfaces between chains.
- L–H · 1864 Ų buried · 15 hydrogen bonds · protein-protein
- B–A · 1836 Ų buried · 15 hydrogen bonds · protein-protein
- A–C · 556 Ų buried · 6 hydrogen bonds · protein-protein
- H–P · 520 Ų buried · 6 hydrogen bonds · protein-protein
- L–P · 294 Ų buried · 7 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 8 disulfide (disulfide).
Compared structures
- 3QWO · Crystal structure of a motavizumab epitope-scaffold bound to motavizumab Fab · the same entry in another collection · chain L against L, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Elsewhere: RCSB PDB 3QWO · PDBe 3QWO
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.